The preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVac’s first-generation mRNA backbone
The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals
Sputnik Light is the first component (recombinant human adenovirus serotype number 26 (rAd26)) of Sputnik
Domestic market and developing countries will need doses of Indian vaccines
Serum buys 50 per cent stake in Indian joint venture of SCHOTT Kaisha
This is the first of its kind vaccine for Covid 19 to get the go-ahead
It falls under the Department of Biotechnology - Mission Covid Suraksha Project for augmenting manufacturing capacity for Covaxin
Studies include Alpha, Beta, Gamma, Delta, Epsilon and Iota and it maintains antibodies for six months after the second dose
Sputnik V is a two-dose shot and has an efficacy of 91.6% against COVID 19
The sales of vaccines have registered a growth of 41% in Q1 FY22, and the sale of health products have registered a growth of 94% in Q1 FY22.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
